Related Experiment Video
Updated: May 10, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Rheumatic manifestations in inflammatory bowel disease
Fabiola Atzeni1, Caterina Defendenti, Maria Chiara Ditto
1Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Musculoskeletal symptoms are common in inflammatory bowel disease (IBD). Ultrasonography (US) effectively detects early joint and entheseal changes in IBD-associated spondyloarthropathies (SpA), aiding diagnosis and treatment decisions.
Area of Science:
- Rheumatology and Gastroenterology
- Diagnostic Imaging in Inflammatory Diseases
Background:
- Musculoskeletal symptoms, including articular, periarticular, and muscular involvement, are frequent extra-intestinal manifestations of inflammatory bowel disease (IBD), affecting 6-46% of patients.
- IBD-related arthropathy is classified within seronegative spondyloarthropathies (SpA), encompassing conditions like ankylosing spondylitis (AS), reactive arthritis, and psoriatic arthritis.
- Articular involvement in IBD significantly impairs patients' quality of life.
Purpose of the Study:
- To highlight the prevalence and impact of musculoskeletal symptoms in IBD patients.
- To evaluate the utility of ultrasonography (US) in diagnosing SpA features in IBD.
- To discuss therapeutic implications, including anti-TNF agents for AS and IBD.
Main Methods:
- Review of current literature on IBD-related musculoskeletal manifestations.
- Comparison of diagnostic capabilities of magnetic resonance imaging (MRI) and ultrasonography (US) for entheseal involvement.
- Analysis of treatment guidelines for SpA in the context of IBD.
Main Results:
- Ultrasonography (US) is a non-invasive, reproducible method for detecting early pathological changes in SpA.
- US can identify characteristic SpA features such as enthesitis, bone erosions, synovitis, bursitis, and tenosynovitis.
- Anti-TNF therapies (adalimumab, infliximab) are beneficial for treating axial and peripheral symptoms in AS and IBD patients with active disease.
Conclusions:
- Ultrasonography (US) is a valuable tool for the early diagnosis and monitoring of SpA in patients with IBD.
- Effective management of IBD-associated musculoskeletal symptoms can improve patients' quality of life.
- Anti-TNF agents represent an important therapeutic option for refractory SpA and IBD-related arthritis and enthesitis.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Inflammatory Bowel Disease II: Ulcerative Colitis
